The Centre yesterday issued guidelines for COVID-19 vaccination of children aged 12 to 14, which will begin from today, and stated that only the Corbevax vaccine would be used for those in this age group.
The instructions stated that recipients between the ages of 12 and 14 would get two doses of Biological E’s intramuscular vaccination Corbevax at 28-day intervals.
In a letter sent to states on Monday, the Centre also offered these instructions.
COVID-19 immunisation of children aged 12-14 years will begin on March 16, while only the Corbevax vaccine will be administered for recipients aged 12-13 and 13-14 years, according to the announcement.
Beneficiaries aged 14-15 years have previously been vaccinated, as have those aged 15-18 years.
All beneficiaries born in 2010 or before – those who have reached the age of 12 – will be allowed to register on CoWIN, according to the criteria.
The registration may be done in one of two ways: self-registration using an existing account on Co-WIN of a family member or by creating a new account using a unique mobile number (this option is now available to all eligible people).
It may also be done onsite by the vaccinator in assisted registration mode, and appointments for 12-14 years can be arranged online or onsite (walk-in).
Vaccination of 12-14-year-olds would be done through specialised inoculation sessions – that is, COVID-19 immunisation centres for 12-14-year-olds – to minimise unintentional vaccination with other COVID-19 vaccinations.